Literature DB >> 21831765

Analysis of the human intestinal epithelial cell transcriptional response to Lactobacillus acidophilus, Lactobacillus salivarius, Bifidobacterium lactis and Escherichia coli.

H Putaala1, R Barrangou, G J Leyer, A C Ouwehand, E Bech Hansen, D A Romero, N Rautonen.   

Abstract

The complex microbial population residing in the human gastrointestinal tract consists of commensal, potential pathogenic and beneficial species, which are probably perceived differently by the host and consequently could be expected to trigger specific transcriptional responses. Here, we provide a comparative analysis of the global in vitro transcriptional response of human intestinal epithelial cells to Lactobacillus acidophilus NCFM™, Lactobacillus salivarius Ls-33, Bifidobacterium animalis subsp. lactis 420, and enterohaemorrhagic Escherichia coli O157:H7 (EHEC). Interestingly, L. salivarius Ls-33 DCE-induced changes were overall more similar to those of B. lactis 420 than to L. acidophilus NCFM™, which is consistent with previously observed in vivo immunomodulation properties. In the gene ontology and pathway analyses both specific and unspecific changes were observed. Common to all was the regulation of apoptosis and adipogenesis, and lipid-metabolism related regulation by the probiotics. Specific changes such as regulation of cell-cell adhesion by B. lactis 420, superoxide metabolism by L. salivarius Ls-33, and regulation of MAPK pathway by L. acidophilus NCFM™ were noted. Furthermore, fundamental differences were observed between the pathogenic and probiotic treatments in the Toll-like receptor pathway, especially for adapter molecules with a lowered level of transcriptional activation of MyD88, TRIF, IRAK1 and TRAF6 by probiotics compared to EHEC. The results in this study provide insights into the relationship between probiotics and human intestinal epithelial cells, notably with regard to strain-specific responses, and highlight the differences between transcriptional responses to pathogenic and probiotic bacteria.

Entities:  

Mesh:

Year:  2010        PMID: 21831765     DOI: 10.3920/BM2010.0003

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  6 in total

Review 1.  Gene-environment interactions in inflammatory bowel disease: microbiota and genes.

Authors:  Marian C Aldhous
Journal:  Frontline Gastroenterol       Date:  2012-05-21

Review 2.  Immunomodulation for gastrointestinal infections.

Authors:  Roberto J Cieza; Anthony T Cao; Yingzi Cong; Alfredo G Torres
Journal:  Expert Rev Anti Infect Ther       Date:  2012-03       Impact factor: 5.091

3.  Influence of exposure time on gene expression by human intestinal epithelial cells exposed to Lactobacillus acidophilus.

Authors:  Sarah O'Flaherty; Todd R Klaenhammer
Journal:  Appl Environ Microbiol       Date:  2012-05-04       Impact factor: 4.792

4.  Effects of the Probiotic Enterococcus faecium and Pathogenic Escherichia coli Strains in a Pig and Human Epithelial Intestinal Cell Model.

Authors:  Ulrike Lodemann; Julia Strahlendorf; Peter Schierack; Shanti Klingspor; Jörg R Aschenbach; Holger Martens
Journal:  Scientifica (Cairo)       Date:  2015-03-26

5.  Lactobacillus paracasei CNCM I-4034 and its culture supernatant modulate Salmonella-induced inflammation in a novel transwell co-culture of human intestinal-like dendritic and Caco-2 cells.

Authors:  Miriam Bermudez-Brito; Sergio Muñoz-Quezada; Carolina Gómez-Llorente; Esther Matencio; Fernando Romero; Angel Gil
Journal:  BMC Microbiol       Date:  2015-04-01       Impact factor: 3.605

Review 6.  Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research.

Authors:  Henna-Maria Uusitupa; Pia Rasinkangas; Markus J Lehtinen; Sanna M Mäkelä; Kaisa Airaksinen; Heli Anglenius; Arthur C Ouwehand; Johanna Maukonen
Journal:  Nutrients       Date:  2020-03-25       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.